The Journal of Organic Chemistry
Note
1
compound 4 as a white solid (0.31 g, 60% yield): mp 66−68 °C; H
NMR (CDCl3) δ 2.14 (s, 3H), 2.23 (s, 3H), 3.63 (s, 3H), 4.12−4.14
(d, J = 4.9 Hz, 1H), 4.42−4.55 (m, 3H), 4.75−4.78 (dd, J = 4.5 Hz, 9.5
Hz, 1H), 5.89 (s, 1H), 8.39 (s, 1H); 13C NMR (CDCl3) δ 20.5, 21.1,
59.2, 61.0, 68.5, 79.1, 81.5, 90.1, 97.5, 143.7, 151.4, 166.1, 170.0, 170.1;
HR-ESI-MS m/z calcd for C14H16BrClN2O7 (M + Na)+ 460.9722,
found 460.9730.
152.09; HR-ESI-MS m/z calcd C52H62N6O10P (M + Na)+ 984.4157,
found 984.4191.
RNA Synthesis, Purification, and Characterization. RNA
solid-phase syntheses were performed on a Pharmacia Gene Assembler
Plus, using polystyrene custom primer support from GE Healthcare.
2′-O-TOM-protected ribonucleoside phosphoramidites were used for
all unmodified RNA nucleotide positions. CT-modified RNA was
prepared as previously described using a convertible O4-(4-
Compound 6. A solution of compounds 519 (87 mg, 0.42 mmol)
and 4 (223 mg, 0.51 mmol) in CH2Cl2 (10 mL) was treated with Et3N
(55.5 mg, 0.55 mmol) at 22 °C. After 16 h, the solvent was removed in
vacuo and the crude product was used directly for the next reaction
without further purification.
chlorophenyl)uridine phosphoramidite.11
synthesized using phosphoramidite 1. Since the C
Ç
m-modified RNA was
̧
m phosphoramidite
1 had limited solubility in acetonitrile, it was dissolved at a
concentration of 100 mM in 1,2-dichloroethane. The coupling time
was set to 3 min using 250 mM benzylthiotetrazole as a coupling
agent. Oxidation was performed with 1 M tert-butylhydroperoxide in
Compound 7. KF (245 mg, 4.22 mmol) was added to a solution of
compound 6 (257 mg, 0.42 mmol crude from previous step) in
absolute ethanol (32 mL). After refluxing for 5 days, the solution was
filtered and the solvent was removed in vacuo. The product was
purified by silica gel flash column chromatography (CH2Cl2/MeOH;
100:0 to 65:35) to yield 7 as dark yellow solid (93 mg, 50% yield): mp
toluene, inspired by recent reports on the stability of Ç under these
conditions.20 Capping and detritylation were performed under
standard conditions for RNA synthesis with 2′-O-TOM phosphor-
amidites. The Çm-containing RNA oligonucleotides were deprotected
1
(decomp.) 160−162 °C; H NMR (MeOH-d4) δ 1.44 (d, J = 1.2 Hz,
by treatment with 8 M methylamine in ethanol/H2O 1/1 at 37 °C for
5−6 h, followed by 2′-O-TOM deprotection with 1 M tetrabuty-
lammonium fluoride (TBAF) in THF at 25 °C for 12−16 h. After
desalting on a Sephadex G10 column, the quality of the crude product
was checked by analytical anion exchange HPLC on a Dionex
DNAPac PA200 column, 4.6 × 250 mm, flow rate 1 mL/min, 80 °C,
buffer A: 25 mM Tris·HCl pH 8.0, 6 M urea; buffer B: buffer A + 0.5
M NaClO4, linear gradient of B in A, with a slope of 4% per column
volume. RNA oligonucleotides were purified by semipreparative anion
exchange HPLC under denaturing conditions on a Dionex DNAPac
PA100 column, 9 × 250 mm, flow rate 2 mL/min, 80 °C, buffers A
and B as for analytical column. Detection was by UV absorbance at
280 nm. Fractions containing full-length RNA were collected and
desalted on SepPak cartridges (Waters). RNA concentration was
determined by UV absorbance at 260 nm, and the product identity was
confirmed by ESI-MS (Table S1). RNA samples were stored as
aqueous solutions at −20 °C.
12H), 3.57 (s, 3H), 3.74−3.84 (m, 2H), 3.91−3.97 (m, 2H), 4.21−
4.24 (dd, J = 6.8 Hz, 5.17 Hz, 1H), 5.89 (d, J = 2.6 Hz), 6.60−6.61 (d,
J = 4.1 Hz, 2H), 7.86 (s, 1H); 13C NMR (MeOH-d4) δ 31.0, 31.1,
58.9, 61.1, 64.9, 64.9, 69.3, 85.5, 89.6, 109.6, 110.7, 123.7, 127.8, 129.6,
143.7, 144.1, 144.6, 155.9, 156.3; HR-ESI-MS m/z calcd for
C22H28N4O6 (M + H)+ 445.2082, found 445.2093.
Rigid Spin Label Çm. A solution of 7 (90 mg, 0.20 mmol) in
MeOH (5.5 mL), containing NaHCO3 (17 mg, 0.20 mmol), was
treated dropwise with H2O2 (70% w/v, 1.11 g/mL, 0.06 mL, 1.42
mmol). After 5 min, Na2WO4 (10 mg, 0.03 mmol) was added and the
resulting mixture was stirred for 30 h at 22 °C. The salts were filtered
and discarded, the filtrate was concentrated in vacuo, and the residue
was purified by flash column chromatography (CH2Cl2/MeOH; 100:0
to 85:15) to yield Çm as a yellow solid (47 mg, 51% yield): mp
(decomp.) 230−232 °C; 1H NMR (DMSO-d6) δ 2.08 (br s), 3.41 (br
s), 3.70 (br s), 3.85 (br s), 4.13 (br s), 5.09 (br s), 5.26 (br s), 5.88 (br
s), 7.52 (br s), 8.54 (s), 10.72 (br s); 13C NMR (DMSO-d6) δ 30.5,
57.3, 59.6, 67.5, 82.8, 84.0, 86.0, 86.2, 95.4, 125.2, 139.6, 149.2, 151.2,
151.4, 158.6; HR-ESI-MS m/z calcd for C22H27N4O7 (M + Na)+
482.1772, found 482.1785.
Melting curves were measured in 10 mM potassium phosphate
buffer, pH 7.0, 150 mM NaCl, on a Cary 100 UV spectrophotometer
(Varian Inc.) equipped with a multiple cell holder and a Peltier
temperature-control device. RNA sample concentration was from 2 to
40 μM. Temperature-dependent changes in UV absorbance were
measured at 250, 260, 270, and 280 nm, with a heating/cooling rate of
0.7 °C/min. Two full heating and cooling cycles (4 ramps) were
collected, and all melting transitions were fully reversible and
reproducible. Thermodynamic parameters for the duplices 8+9 were
obtained from concentration-dependent melting curves by analysis of
ln(cT) versus 1/Tm.
5′-(4,4′-Dimethoxytrityl) Çm. Spin-labeled nucleoside Çm (20.0
mg, 0.04 mmol), DMTCl (22.1 mg, 0.06 mmol), and DMAP (0.6 mg,
0.004 mmol) were added to a round-bottom flask and kept under
vacuum for 16 h. Anhydrous pyridine (1 mL) was added, and the
resulting solution was stirred for 4 h, after which MeOH (100 μL) was
added and the solvent removed in vacuo. The residue was purified by
column chromatography (Et3N/CH2Cl2/MeOH; 1:99:0 to 1:95:4) to
yield tritylated C
̧
m as a yellow solid (20 mg, 60% yield): mp
CD spectra were recorded on a Chirascan CD spectrophotometer
(Applied Photophysics) at an RNA duplex concentration of 10 or 40
μM in 10 mM potassium phosphate buffer, pH 7.0, 150 mM NaCl, at
25 °C, with 0.5 nm step size and 2 s/data point. Data were collected in
three repetitions and averaged. CD spectra are depicted in Supporting
Information Figures S1 and S3.
(decomp.) 150−152 °C; 1H NMR (DMSO-d6) δ 3.45 (br s), 3.74 (br
s), 3.96 (br s), 4.25 (br s), 5.19 (br s), 5.83 (br s), 6.93 (br s), 7.33−
7.44 (br s), 10.65 (br s); 13C NMR (DMSO-d6) δ 57.6, 62.1, 68.1,
82.0, 82.7, 85.6, 86.9, 113.0, 113.1, 126.6, 127.6, 127.6, 127.7, 127.8,
129.4, 129.5, 135.1, 135.4, 144.2, 157.8; HR-ESI-MS m/z calcd
C43H45N4O9 (M + Na)+ 784.3079, found 784.3083.
EPR Experiments. Aliquots of RNA samples were lyophilized and
dissolved in buffer. The buffer composition was 10 mM potassium
phosphate buffer, pH 7.0 containing 150 mM NaCl. The final
concentration of the spin-labeled RNA was 10−25 μM. For
bimolecular samples with only one spin-labeled strand, the unmodified
complementary strand was used in 1.5-fold excess; for the trimolecular
constructs, the short unmodified strand (14 or 15) was in 10-fold
excess. For the duplex sample containing two single-labeled strands,
equimolar amounts of 10a+11a were used. All samples were heated to
90 °C for 3 min and slowly cooled to 22 °C. The EPR samples (15
μL) were placed in quartz capillaries sealed at one end. CW-EPR
spectra were recorded at 23 °C at X-band (9 GHz) over 160 G on a
Bruker Elexsys 500 spectrometer fitted with a high-sensitivity
resonator using 20 mW incident microwave power and 1 G field
modulation amplitude at 100 kHz modulation frequency. From the
CW-EPR spectra, the peak-to-peak line width of the central line (ΔH0,
in mT) and the separation between the resonances of the low- and
high-field lines (2Azz, in mT) were extracted (Supporting Table S3)
C
̧
m Phosphoramidite (1). Diisopropyl ammonium tetrazolide
(24 mg, 0.14 mmol) and tritylated Cm (70.0 mg, 0.09 mmol) were
̧
dissolved in pyridine, the pyridine was removed in vacuo, and the
residue was kept under vacuum for 16 h. CH2Cl2 (4 mL) was added,
along with 2-cyanoethyl N,N,N′,N′-tetraisopropyldiamidophosphite
(88 μL, 0.28 mmol), and the resulting solution was stirred for 5 h at 22
°C. CH2Cl2 (10 mL) was added, and the organic phase was washed
with saturated aqueous NaHCO3 (3 × 15 mL) and saturated aqueous
NaCl (3 × 15 mL), dried over Na2SO4, and concentrated in vacuo.
The residue was dissolved in a minimum amount of diethyl ether (7−9
mL), followed by a slow addition of hexane (40−50 mL) at 22 °C.
The solvent was decanted and discarded. Finally, the compound was
purified by column chromatography using neutral silica gel (EtOAc) to
yield 1 as a yellow solid (40 mg, 46% yield): mp (decomp.) 130−132
1
°C; H NMR (CDCl3) δ 1.24−1.63 (br m), 2.82 (br s), 3.04 (br s),
4.15 (br s), 4.50 (br s), 4.64 (br s), 4.87 (br s), 5.10 (br s), 5.62 (br s),
6.42 (br s), 7.26 (br s), 7.82 (br s); 31P NMR (CDCl3) δ 150.59,
7753
dx.doi.org/10.1021/jo301227w | J. Org. Chem. 2012, 77, 7749−7754